187 related articles for article (PubMed ID: 4993152)
1. Immunochemical study of Mycobacteria firmly bound lipids.
Hiu IJ; Amiel JL; Nikdjou K
Rev Eur Etud Clin Biol; 1970 Oct; 15(8):887-91. PubMed ID: 4993152
[No Abstract] [Full Text] [Related]
2. Mycobacterial adjuvant. I. Purification of an adjuvant-active component from wax D(H 37 Ra strain) by preparative thin-layer chromatography.
Kumazawa Y; Tsushida A; Mizunoe K; Suzuki T; Kawanishi Y
Jpn J Microbiol; 1972 Jan; 16(1):73-5. PubMed ID: 4625075
[No Abstract] [Full Text] [Related]
3. [Biological reactions induced by a lipopolysaccharide (wax D) of mycobacteria with special reference to adjuvant activity].
Tanaka A
Kekkaku; 1971 May; 46(3):41-51. PubMed ID: 4994699
[No Abstract] [Full Text] [Related]
4. Immunological adjuvants. V. A critical evaluation of minimal requirements for mycobacterial adjuvants to induce delayed hypersensitivity.
Ishibashi T; Hagimoto D; Shinozaki S; Tanaka A; Sugiyama K
Jpn J Exp Med; 1971 Apr; 41(2):95-102. PubMed ID: 4994872
[No Abstract] [Full Text] [Related]
5. Isolation of immunological adjuvant component from B.C.G. cells.
Hiu IJ; Amiel JL
Rev Eur Etud Clin Biol; 1971; 16(1):55-8. PubMed ID: 4929110
[No Abstract] [Full Text] [Related]
6. Modification of Listeria monocytogenes infection during unrelated cell-mediated immune reactions.
Dodd RY; Nash C
J Reticuloendothel Soc; 1971 Dec; 10(6):501-14. PubMed ID: 4109475
[No Abstract] [Full Text] [Related]
7. Comparison of chemical and biological properties of water-soluble adjuvants prepared from Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium smegmatis.
Kumazawa Y; Shibusawa A; Nakagawa N; Kojima Y; Mizunoe K
Kitasato Arch Exp Med; 1976 Dec; 49(4):153-62. PubMed ID: 829910
[No Abstract] [Full Text] [Related]
8. The lipid composition of pathogenic and saprophytic mycobacteria.
Tuboly S
Acta Microbiol Acad Sci Hung; 1968; 15(3):207-12. PubMed ID: 4976379
[No Abstract] [Full Text] [Related]
9. [Studies on adjuvant activity of wax D fraction of mycobacteria].
Someya S
Kekkaku; 1968 Aug; 43(8):328-31. PubMed ID: 4974528
[No Abstract] [Full Text] [Related]
10. Delayed type hypersensitivity and antituberculous immunity.
Averbakh MM; Gergert VY; Kluyev VA; Kolodiazhnaya NS; Litvinsov VI; Moroz AM
Z Immunitatsforsch Exp Klin Immunol; 1974 Aug; 147(3):204-16. PubMed ID: 4283014
[No Abstract] [Full Text] [Related]
11. The isolation from romanian BCG substrain of non cross reacting antigens to Mycobacterium tuberculosis H37Rv strain.
Niculescu D; Stavri D; Stavri H; Claiciu I; Bărbulescu R
Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):213-9. PubMed ID: 6424629
[No Abstract] [Full Text] [Related]
12. The role played the lipid fractions of Mycobacterium bovis BCG in the development of antituberculosis immunity in an animal experiment.
Sír Z; Průchová J; Mára M; Mohelská H; Nedvĕdová V; Hyncica V
J Hyg Epidemiol Microbiol Immunol; 1991; 35(1):73-82. PubMed ID: 1715358
[TBL] [Abstract][Full Text] [Related]
13. Separation of an adjuvant-active glycolipid lacking peptide moiety from wax D preparation of Mycobacterium tuberculosis strain aoyama B.
Kumazawa Y; Shibusawa A; Suzuki T; Mizunoe K
Immunochemistry; 1976 Feb; 13(2):173-7. PubMed ID: 816734
[No Abstract] [Full Text] [Related]
14. Experimental immunity against tuberculosis evoked by peptidoglycolipids of the wax D type.
Pokorný J; Sulová J; Zák F
Z Immunitatsforsch Allerg Klin Immunol; 1968 Aug; 136(2):118-28. PubMed ID: 4234690
[No Abstract] [Full Text] [Related]
15. [Immunological properties of cellular membranes of Mycobacterium bovis].
Romanova RIu; Pavlova VT; Il'ina IN; Kliuev VA
Probl Tuberk; 1978 Aug; (8):67-70. PubMed ID: 360207
[No Abstract] [Full Text] [Related]
16. Nonliving immunogenic substances of Mycobacteria.
Smith DW; Grover AA; Wiegeshaus E
Bibl Tuberc; 1968; 24():191-227. PubMed ID: 4983194
[No Abstract] [Full Text] [Related]
17. Currents in tuberculosis research.
Ribi E
J Infect Dis; 1971 May; 123(5):562-5. PubMed ID: 5000472
[No Abstract] [Full Text] [Related]
18. Tuberculin sensitization with an acidic residual protein and purified wax of tubercle bacillus.
Ueda K; Yamazaki S; Someya S; Tsumita T; Kanai K
Jpn J Exp Med; 1972 Aug; 42(4):419-21. PubMed ID: 4627022
[No Abstract] [Full Text] [Related]
19. [Attempts at isolation and characterization of immunogenically active fractions from Mycobacterium tuberculosis and Mycobacterium bovis (BCG). IV. Immunobiologic properties of the fractions].
Klose F; Schallehn G
Z Immunitatsforsch Allerg Klin Immunol; 1966 Sep; 131(3):219-35. PubMed ID: 4231180
[No Abstract] [Full Text] [Related]
20. [The feasibility of using the fluorescent antibody technic in immunologic studies of tuberculosis].
Gogebashvili NV; Averbakh MM
Biull Eksp Biol Med; 1967 Sep; 64(9):71-4. PubMed ID: 4988303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
